anti cyc Search Results


88
Novus Biologicals α cytochrome c
α Cytochrome C, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/α cytochrome c/product/Novus Biologicals
Average 88 stars, based on 1 article reviews
α cytochrome c - by Bioz Stars, 2026-02
88/100 stars
  Buy from Supplier

95
Miltenyi Biotec cd73
Perfusion improved the integrity and cell viability of the FH model and resulted in an RNA pattern representing the initial phase of fracture healing. A) Schematic illustration of the cultivation profile B) Diameter of the in vitro FHs before and after incubation ( n = 4) and C) the frequency of total cells, MSCs <t>(CD73</t> + , CD90 + , and CD45 − ), and neutrophil granulocytes (CD45 + , CD15 + ), negative for 7‐AAD in the in vitro FHs cultured in osteogenic differentiation medium for 5 days ( n = 7). Data are shown as bar charts with SEM. Statistics were performed using the Mann‐Whitney U test. D) Relative gene expression of osteogenic (RUNX2), angiogenic (VEGFA), metabolic (LDHA), matrix‐degrading and migratory (MMP2, MMP9, CXCR4), and inflammatory (IL6, IL8) marker genes after incubation of the in vitro FH models in osteogenic medium for 2 days under perfused conditions, compared to static conditions (dotted line) for n = 4. Data are shown as box plots. Statistical analysis was performed using the one‐sample t‐test versus the hypothetical value 1. The dotted line represents the hypothetical value 1 under static conditions. P ‐values are indicated in the graphs with # p > 0.1, * p < 0.05, ** p < 0.01, *** p < 0.001 **** p < 0.0001. E) Relative gene expression of osteogenic (RUNX2), angiogenic (VEGFA), metabolic (LDHA) matrix‐degrading and migratory (MMP2, MMP9, CXCR4) and F) inflammatory (IL6, IL8) and anti‐inflammatory (IL4, IL13) marker genes after incubation of the in vitro FH models in osteogenic medium for 2 or 5 days under perfused conditions ( n = 3‐4) compared to day 0 (dotted line). Data are shown as box plots. Statistical analysis was performed using the one‐sample t‐test to compare 2 and 5 days with 0 days, and the t‐test to compare 2 and 5 days. P‐values are indicated in the graphs with # p < 0.1, * p < 0.05, *** p < 0.001, **** p < 0.0001.
Cd73, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd73/product/Miltenyi Biotec
Average 95 stars, based on 1 article reviews
cd73 - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier

93
Boster Bio rabbit anti caspase 3
Perfusion improved the integrity and cell viability of the FH model and resulted in an RNA pattern representing the initial phase of fracture healing. A) Schematic illustration of the cultivation profile B) Diameter of the in vitro FHs before and after incubation ( n = 4) and C) the frequency of total cells, MSCs <t>(CD73</t> + , CD90 + , and CD45 − ), and neutrophil granulocytes (CD45 + , CD15 + ), negative for 7‐AAD in the in vitro FHs cultured in osteogenic differentiation medium for 5 days ( n = 7). Data are shown as bar charts with SEM. Statistics were performed using the Mann‐Whitney U test. D) Relative gene expression of osteogenic (RUNX2), angiogenic (VEGFA), metabolic (LDHA), matrix‐degrading and migratory (MMP2, MMP9, CXCR4), and inflammatory (IL6, IL8) marker genes after incubation of the in vitro FH models in osteogenic medium for 2 days under perfused conditions, compared to static conditions (dotted line) for n = 4. Data are shown as box plots. Statistical analysis was performed using the one‐sample t‐test versus the hypothetical value 1. The dotted line represents the hypothetical value 1 under static conditions. P ‐values are indicated in the graphs with # p > 0.1, * p < 0.05, ** p < 0.01, *** p < 0.001 **** p < 0.0001. E) Relative gene expression of osteogenic (RUNX2), angiogenic (VEGFA), metabolic (LDHA) matrix‐degrading and migratory (MMP2, MMP9, CXCR4) and F) inflammatory (IL6, IL8) and anti‐inflammatory (IL4, IL13) marker genes after incubation of the in vitro FH models in osteogenic medium for 2 or 5 days under perfused conditions ( n = 3‐4) compared to day 0 (dotted line). Data are shown as box plots. Statistical analysis was performed using the one‐sample t‐test to compare 2 and 5 days with 0 days, and the t‐test to compare 2 and 5 days. P‐values are indicated in the graphs with # p < 0.1, * p < 0.05, *** p < 0.001, **** p < 0.0001.
Rabbit Anti Caspase 3, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti caspase 3/product/Boster Bio
Average 93 stars, based on 1 article reviews
rabbit anti caspase 3 - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

92
Proteintech primary antibodies against ccny
( a ) Schematic diagram of <t>CCNY</t> domain structure. Numbers indicate amino acid residues. Domain is predicted by ScanProsite ( http://www.expasy.ch/tools/scanprosite/ ) . ( b ) Alignment of CCNY amino acid sequences among human, rat, and mouse was performed using NCBI BLAST program. Blue color indicates amino acids showing differences among species. Orange indicates cyclin box domain in CCNY. ( c ) CCNY expression levels in the several regions of rat brain. Quantification is shown in the lower panel (n = 3; postnatal day 30 male rats). An equal amount of protein (40 μg) from each region was loaded. CTX, cortex; ST, striatum; HC, hippocampus; TH, thalamus; SN, substantia nigra; CB, cerebellum. ( d ) CCNY expression in the DG, CA3, and CA1 in the hippocampus. Postnatal day 30 male rats. ( e , f ) Hippocampal expression levels of CCNY in vivo ( e ) and in vitro ( f ) during development. P, postnatal day; DIV, days in vitro . ( g ) Distribution of CCNY in subcellular fractions of rat brains. H, homogenates; P1, nuclear pellet; P2, crude synaptosomal fraction; S3, cytosolic fraction; LP1, synaptosomal membrane fraction; LP2, synaptic vesicle-enriched fraction; SPM, synaptic plasma membrane fraction; T-sol, Tx-100-soluble fraction; PSD, postsynaptic density fraction. A total of 5 μg of each fraction was loaded in immunoblot <t>experiments.</t> <t>GluA1,</t> PSD-95 and synaptophysin were used as controls. ( h ) CCNY is localized adjacent to PSD-95 in spines. Scale bars, 1 μm. 3D iso-surfaced and volume rendered images with various angle views are shown in hi − hv .
Primary Antibodies Against Ccny, supplied by Proteintech, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary antibodies against ccny/product/Proteintech
Average 92 stars, based on 1 article reviews
primary antibodies against ccny - by Bioz Stars, 2026-02
92/100 stars
  Buy from Supplier

96
Proteintech 10993 1 ap
( a ) Schematic diagram of <t>CCNY</t> domain structure. Numbers indicate amino acid residues. Domain is predicted by ScanProsite ( http://www.expasy.ch/tools/scanprosite/ ) . ( b ) Alignment of CCNY amino acid sequences among human, rat, and mouse was performed using NCBI BLAST program. Blue color indicates amino acids showing differences among species. Orange indicates cyclin box domain in CCNY. ( c ) CCNY expression levels in the several regions of rat brain. Quantification is shown in the lower panel (n = 3; postnatal day 30 male rats). An equal amount of protein (40 μg) from each region was loaded. CTX, cortex; ST, striatum; HC, hippocampus; TH, thalamus; SN, substantia nigra; CB, cerebellum. ( d ) CCNY expression in the DG, CA3, and CA1 in the hippocampus. Postnatal day 30 male rats. ( e , f ) Hippocampal expression levels of CCNY in vivo ( e ) and in vitro ( f ) during development. P, postnatal day; DIV, days in vitro . ( g ) Distribution of CCNY in subcellular fractions of rat brains. H, homogenates; P1, nuclear pellet; P2, crude synaptosomal fraction; S3, cytosolic fraction; LP1, synaptosomal membrane fraction; LP2, synaptic vesicle-enriched fraction; SPM, synaptic plasma membrane fraction; T-sol, Tx-100-soluble fraction; PSD, postsynaptic density fraction. A total of 5 μg of each fraction was loaded in immunoblot <t>experiments.</t> <t>GluA1,</t> PSD-95 and synaptophysin were used as controls. ( h ) CCNY is localized adjacent to PSD-95 in spines. Scale bars, 1 μm. 3D iso-surfaced and volume rendered images with various angle views are shown in hi − hv .
10993 1 Ap, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/10993 1 ap/product/Proteintech
Average 96 stars, based on 1 article reviews
10993 1 ap - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier

91
ProSci Incorporated high content software hcs
( a ) Schematic diagram of <t>CCNY</t> domain structure. Numbers indicate amino acid residues. Domain is predicted by ScanProsite ( http://www.expasy.ch/tools/scanprosite/ ) . ( b ) Alignment of CCNY amino acid sequences among human, rat, and mouse was performed using NCBI BLAST program. Blue color indicates amino acids showing differences among species. Orange indicates cyclin box domain in CCNY. ( c ) CCNY expression levels in the several regions of rat brain. Quantification is shown in the lower panel (n = 3; postnatal day 30 male rats). An equal amount of protein (40 μg) from each region was loaded. CTX, cortex; ST, striatum; HC, hippocampus; TH, thalamus; SN, substantia nigra; CB, cerebellum. ( d ) CCNY expression in the DG, CA3, and CA1 in the hippocampus. Postnatal day 30 male rats. ( e , f ) Hippocampal expression levels of CCNY in vivo ( e ) and in vitro ( f ) during development. P, postnatal day; DIV, days in vitro . ( g ) Distribution of CCNY in subcellular fractions of rat brains. H, homogenates; P1, nuclear pellet; P2, crude synaptosomal fraction; S3, cytosolic fraction; LP1, synaptosomal membrane fraction; LP2, synaptic vesicle-enriched fraction; SPM, synaptic plasma membrane fraction; T-sol, Tx-100-soluble fraction; PSD, postsynaptic density fraction. A total of 5 μg of each fraction was loaded in immunoblot <t>experiments.</t> <t>GluA1,</t> PSD-95 and synaptophysin were used as controls. ( h ) CCNY is localized adjacent to PSD-95 in spines. Scale bars, 1 μm. 3D iso-surfaced and volume rendered images with various angle views are shown in hi − hv .
High Content Software Hcs, supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/high content software hcs/product/ProSci Incorporated
Average 91 stars, based on 1 article reviews
high content software hcs - by Bioz Stars, 2026-02
91/100 stars
  Buy from Supplier

93
Proteintech p2y12
( a ) Schematic diagram of <t>CCNY</t> domain structure. Numbers indicate amino acid residues. Domain is predicted by ScanProsite ( http://www.expasy.ch/tools/scanprosite/ ) . ( b ) Alignment of CCNY amino acid sequences among human, rat, and mouse was performed using NCBI BLAST program. Blue color indicates amino acids showing differences among species. Orange indicates cyclin box domain in CCNY. ( c ) CCNY expression levels in the several regions of rat brain. Quantification is shown in the lower panel (n = 3; postnatal day 30 male rats). An equal amount of protein (40 μg) from each region was loaded. CTX, cortex; ST, striatum; HC, hippocampus; TH, thalamus; SN, substantia nigra; CB, cerebellum. ( d ) CCNY expression in the DG, CA3, and CA1 in the hippocampus. Postnatal day 30 male rats. ( e , f ) Hippocampal expression levels of CCNY in vivo ( e ) and in vitro ( f ) during development. P, postnatal day; DIV, days in vitro . ( g ) Distribution of CCNY in subcellular fractions of rat brains. H, homogenates; P1, nuclear pellet; P2, crude synaptosomal fraction; S3, cytosolic fraction; LP1, synaptosomal membrane fraction; LP2, synaptic vesicle-enriched fraction; SPM, synaptic plasma membrane fraction; T-sol, Tx-100-soluble fraction; PSD, postsynaptic density fraction. A total of 5 μg of each fraction was loaded in immunoblot <t>experiments.</t> <t>GluA1,</t> PSD-95 and synaptophysin were used as controls. ( h ) CCNY is localized adjacent to PSD-95 in spines. Scale bars, 1 μm. 3D iso-surfaced and volume rendered images with various angle views are shown in hi − hv .
P2y12, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p2y12/product/Proteintech
Average 93 stars, based on 1 article reviews
p2y12 - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

93
Proteintech cytochrome c
( a ) Schematic diagram of <t>CCNY</t> domain structure. Numbers indicate amino acid residues. Domain is predicted by ScanProsite ( http://www.expasy.ch/tools/scanprosite/ ) . ( b ) Alignment of CCNY amino acid sequences among human, rat, and mouse was performed using NCBI BLAST program. Blue color indicates amino acids showing differences among species. Orange indicates cyclin box domain in CCNY. ( c ) CCNY expression levels in the several regions of rat brain. Quantification is shown in the lower panel (n = 3; postnatal day 30 male rats). An equal amount of protein (40 μg) from each region was loaded. CTX, cortex; ST, striatum; HC, hippocampus; TH, thalamus; SN, substantia nigra; CB, cerebellum. ( d ) CCNY expression in the DG, CA3, and CA1 in the hippocampus. Postnatal day 30 male rats. ( e , f ) Hippocampal expression levels of CCNY in vivo ( e ) and in vitro ( f ) during development. P, postnatal day; DIV, days in vitro . ( g ) Distribution of CCNY in subcellular fractions of rat brains. H, homogenates; P1, nuclear pellet; P2, crude synaptosomal fraction; S3, cytosolic fraction; LP1, synaptosomal membrane fraction; LP2, synaptic vesicle-enriched fraction; SPM, synaptic plasma membrane fraction; T-sol, Tx-100-soluble fraction; PSD, postsynaptic density fraction. A total of 5 μg of each fraction was loaded in immunoblot <t>experiments.</t> <t>GluA1,</t> PSD-95 and synaptophysin were used as controls. ( h ) CCNY is localized adjacent to PSD-95 in spines. Scale bars, 1 μm. 3D iso-surfaced and volume rendered images with various angle views are shown in hi − hv .
Cytochrome C, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cytochrome c/product/Proteintech
Average 93 stars, based on 1 article reviews
cytochrome c - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

92
St Johns Laboratory cytochrome c
( a ) Schematic diagram of <t>CCNY</t> domain structure. Numbers indicate amino acid residues. Domain is predicted by ScanProsite ( http://www.expasy.ch/tools/scanprosite/ ) . ( b ) Alignment of CCNY amino acid sequences among human, rat, and mouse was performed using NCBI BLAST program. Blue color indicates amino acids showing differences among species. Orange indicates cyclin box domain in CCNY. ( c ) CCNY expression levels in the several regions of rat brain. Quantification is shown in the lower panel (n = 3; postnatal day 30 male rats). An equal amount of protein (40 μg) from each region was loaded. CTX, cortex; ST, striatum; HC, hippocampus; TH, thalamus; SN, substantia nigra; CB, cerebellum. ( d ) CCNY expression in the DG, CA3, and CA1 in the hippocampus. Postnatal day 30 male rats. ( e , f ) Hippocampal expression levels of CCNY in vivo ( e ) and in vitro ( f ) during development. P, postnatal day; DIV, days in vitro . ( g ) Distribution of CCNY in subcellular fractions of rat brains. H, homogenates; P1, nuclear pellet; P2, crude synaptosomal fraction; S3, cytosolic fraction; LP1, synaptosomal membrane fraction; LP2, synaptic vesicle-enriched fraction; SPM, synaptic plasma membrane fraction; T-sol, Tx-100-soluble fraction; PSD, postsynaptic density fraction. A total of 5 μg of each fraction was loaded in immunoblot <t>experiments.</t> <t>GluA1,</t> PSD-95 and synaptophysin were used as controls. ( h ) CCNY is localized adjacent to PSD-95 in spines. Scale bars, 1 μm. 3D iso-surfaced and volume rendered images with various angle views are shown in hi − hv .
Cytochrome C, supplied by St Johns Laboratory, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cytochrome c/product/St Johns Laboratory
Average 92 stars, based on 1 article reviews
cytochrome c - by Bioz Stars, 2026-02
92/100 stars
  Buy from Supplier

86
Thermo Fisher gene exp cycs hs01588973 m1
( a ) Schematic diagram of <t>CCNY</t> domain structure. Numbers indicate amino acid residues. Domain is predicted by ScanProsite ( http://www.expasy.ch/tools/scanprosite/ ) . ( b ) Alignment of CCNY amino acid sequences among human, rat, and mouse was performed using NCBI BLAST program. Blue color indicates amino acids showing differences among species. Orange indicates cyclin box domain in CCNY. ( c ) CCNY expression levels in the several regions of rat brain. Quantification is shown in the lower panel (n = 3; postnatal day 30 male rats). An equal amount of protein (40 μg) from each region was loaded. CTX, cortex; ST, striatum; HC, hippocampus; TH, thalamus; SN, substantia nigra; CB, cerebellum. ( d ) CCNY expression in the DG, CA3, and CA1 in the hippocampus. Postnatal day 30 male rats. ( e , f ) Hippocampal expression levels of CCNY in vivo ( e ) and in vitro ( f ) during development. P, postnatal day; DIV, days in vitro . ( g ) Distribution of CCNY in subcellular fractions of rat brains. H, homogenates; P1, nuclear pellet; P2, crude synaptosomal fraction; S3, cytosolic fraction; LP1, synaptosomal membrane fraction; LP2, synaptic vesicle-enriched fraction; SPM, synaptic plasma membrane fraction; T-sol, Tx-100-soluble fraction; PSD, postsynaptic density fraction. A total of 5 μg of each fraction was loaded in immunoblot <t>experiments.</t> <t>GluA1,</t> PSD-95 and synaptophysin were used as controls. ( h ) CCNY is localized adjacent to PSD-95 in spines. Scale bars, 1 μm. 3D iso-surfaced and volume rendered images with various angle views are shown in hi − hv .
Gene Exp Cycs Hs01588973 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gene exp cycs hs01588973 m1/product/Thermo Fisher
Average 86 stars, based on 1 article reviews
gene exp cycs hs01588973 m1 - by Bioz Stars, 2026-02
86/100 stars
  Buy from Supplier

94
Miltenyi Biotec anti cd63 fitc antibody
( a ) Schematic diagram of <t>CCNY</t> domain structure. Numbers indicate amino acid residues. Domain is predicted by ScanProsite ( http://www.expasy.ch/tools/scanprosite/ ) . ( b ) Alignment of CCNY amino acid sequences among human, rat, and mouse was performed using NCBI BLAST program. Blue color indicates amino acids showing differences among species. Orange indicates cyclin box domain in CCNY. ( c ) CCNY expression levels in the several regions of rat brain. Quantification is shown in the lower panel (n = 3; postnatal day 30 male rats). An equal amount of protein (40 μg) from each region was loaded. CTX, cortex; ST, striatum; HC, hippocampus; TH, thalamus; SN, substantia nigra; CB, cerebellum. ( d ) CCNY expression in the DG, CA3, and CA1 in the hippocampus. Postnatal day 30 male rats. ( e , f ) Hippocampal expression levels of CCNY in vivo ( e ) and in vitro ( f ) during development. P, postnatal day; DIV, days in vitro . ( g ) Distribution of CCNY in subcellular fractions of rat brains. H, homogenates; P1, nuclear pellet; P2, crude synaptosomal fraction; S3, cytosolic fraction; LP1, synaptosomal membrane fraction; LP2, synaptic vesicle-enriched fraction; SPM, synaptic plasma membrane fraction; T-sol, Tx-100-soluble fraction; PSD, postsynaptic density fraction. A total of 5 μg of each fraction was loaded in immunoblot <t>experiments.</t> <t>GluA1,</t> PSD-95 and synaptophysin were used as controls. ( h ) CCNY is localized adjacent to PSD-95 in spines. Scale bars, 1 μm. 3D iso-surfaced and volume rendered images with various angle views are shown in hi − hv .
Anti Cd63 Fitc Antibody, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti cd63 fitc antibody/product/Miltenyi Biotec
Average 94 stars, based on 1 article reviews
anti cd63 fitc antibody - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

90
ProSci Incorporated g protein coupled membrane estrogen receptor gper gpr30
( a ) Schematic diagram of <t>CCNY</t> domain structure. Numbers indicate amino acid residues. Domain is predicted by ScanProsite ( http://www.expasy.ch/tools/scanprosite/ ) . ( b ) Alignment of CCNY amino acid sequences among human, rat, and mouse was performed using NCBI BLAST program. Blue color indicates amino acids showing differences among species. Orange indicates cyclin box domain in CCNY. ( c ) CCNY expression levels in the several regions of rat brain. Quantification is shown in the lower panel (n = 3; postnatal day 30 male rats). An equal amount of protein (40 μg) from each region was loaded. CTX, cortex; ST, striatum; HC, hippocampus; TH, thalamus; SN, substantia nigra; CB, cerebellum. ( d ) CCNY expression in the DG, CA3, and CA1 in the hippocampus. Postnatal day 30 male rats. ( e , f ) Hippocampal expression levels of CCNY in vivo ( e ) and in vitro ( f ) during development. P, postnatal day; DIV, days in vitro . ( g ) Distribution of CCNY in subcellular fractions of rat brains. H, homogenates; P1, nuclear pellet; P2, crude synaptosomal fraction; S3, cytosolic fraction; LP1, synaptosomal membrane fraction; LP2, synaptic vesicle-enriched fraction; SPM, synaptic plasma membrane fraction; T-sol, Tx-100-soluble fraction; PSD, postsynaptic density fraction. A total of 5 μg of each fraction was loaded in immunoblot <t>experiments.</t> <t>GluA1,</t> PSD-95 and synaptophysin were used as controls. ( h ) CCNY is localized adjacent to PSD-95 in spines. Scale bars, 1 μm. 3D iso-surfaced and volume rendered images with various angle views are shown in hi − hv .
G Protein Coupled Membrane Estrogen Receptor Gper Gpr30, supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/g protein coupled membrane estrogen receptor gper gpr30/product/ProSci Incorporated
Average 90 stars, based on 1 article reviews
g protein coupled membrane estrogen receptor gper gpr30 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Perfusion improved the integrity and cell viability of the FH model and resulted in an RNA pattern representing the initial phase of fracture healing. A) Schematic illustration of the cultivation profile B) Diameter of the in vitro FHs before and after incubation ( n = 4) and C) the frequency of total cells, MSCs (CD73 + , CD90 + , and CD45 − ), and neutrophil granulocytes (CD45 + , CD15 + ), negative for 7‐AAD in the in vitro FHs cultured in osteogenic differentiation medium for 5 days ( n = 7). Data are shown as bar charts with SEM. Statistics were performed using the Mann‐Whitney U test. D) Relative gene expression of osteogenic (RUNX2), angiogenic (VEGFA), metabolic (LDHA), matrix‐degrading and migratory (MMP2, MMP9, CXCR4), and inflammatory (IL6, IL8) marker genes after incubation of the in vitro FH models in osteogenic medium for 2 days under perfused conditions, compared to static conditions (dotted line) for n = 4. Data are shown as box plots. Statistical analysis was performed using the one‐sample t‐test versus the hypothetical value 1. The dotted line represents the hypothetical value 1 under static conditions. P ‐values are indicated in the graphs with # p > 0.1, * p < 0.05, ** p < 0.01, *** p < 0.001 **** p < 0.0001. E) Relative gene expression of osteogenic (RUNX2), angiogenic (VEGFA), metabolic (LDHA) matrix‐degrading and migratory (MMP2, MMP9, CXCR4) and F) inflammatory (IL6, IL8) and anti‐inflammatory (IL4, IL13) marker genes after incubation of the in vitro FH models in osteogenic medium for 2 or 5 days under perfused conditions ( n = 3‐4) compared to day 0 (dotted line). Data are shown as box plots. Statistical analysis was performed using the one‐sample t‐test to compare 2 and 5 days with 0 days, and the t‐test to compare 2 and 5 days. P‐values are indicated in the graphs with # p < 0.1, * p < 0.05, *** p < 0.001, **** p < 0.0001.

Journal: Advanced Healthcare Materials

Article Title: A Modular Perfusion Bioreactor Platform for Simulating Bone Regeneration and Fracture Healing: Integrating Mechanical Loading and Dual Perfusion for Advanced In Vitro Models

doi: 10.1002/adhm.202502492

Figure Lengend Snippet: Perfusion improved the integrity and cell viability of the FH model and resulted in an RNA pattern representing the initial phase of fracture healing. A) Schematic illustration of the cultivation profile B) Diameter of the in vitro FHs before and after incubation ( n = 4) and C) the frequency of total cells, MSCs (CD73 + , CD90 + , and CD45 − ), and neutrophil granulocytes (CD45 + , CD15 + ), negative for 7‐AAD in the in vitro FHs cultured in osteogenic differentiation medium for 5 days ( n = 7). Data are shown as bar charts with SEM. Statistics were performed using the Mann‐Whitney U test. D) Relative gene expression of osteogenic (RUNX2), angiogenic (VEGFA), metabolic (LDHA), matrix‐degrading and migratory (MMP2, MMP9, CXCR4), and inflammatory (IL6, IL8) marker genes after incubation of the in vitro FH models in osteogenic medium for 2 days under perfused conditions, compared to static conditions (dotted line) for n = 4. Data are shown as box plots. Statistical analysis was performed using the one‐sample t‐test versus the hypothetical value 1. The dotted line represents the hypothetical value 1 under static conditions. P ‐values are indicated in the graphs with # p > 0.1, * p < 0.05, ** p < 0.01, *** p < 0.001 **** p < 0.0001. E) Relative gene expression of osteogenic (RUNX2), angiogenic (VEGFA), metabolic (LDHA) matrix‐degrading and migratory (MMP2, MMP9, CXCR4) and F) inflammatory (IL6, IL8) and anti‐inflammatory (IL4, IL13) marker genes after incubation of the in vitro FH models in osteogenic medium for 2 or 5 days under perfused conditions ( n = 3‐4) compared to day 0 (dotted line). Data are shown as box plots. Statistical analysis was performed using the one‐sample t‐test to compare 2 and 5 days with 0 days, and the t‐test to compare 2 and 5 days. P‐values are indicated in the graphs with # p < 0.1, * p < 0.05, *** p < 0.001, **** p < 0.0001.

Article Snippet: CD73 , MSCs , REA804 , Miltenyi Biotec , 130‐111‐909 , REAfinity TM , 1:20.

Techniques: In Vitro, Incubation, Cell Culture, MANN-WHITNEY, Gene Expression, Marker

( a ) Schematic diagram of CCNY domain structure. Numbers indicate amino acid residues. Domain is predicted by ScanProsite ( http://www.expasy.ch/tools/scanprosite/ ) . ( b ) Alignment of CCNY amino acid sequences among human, rat, and mouse was performed using NCBI BLAST program. Blue color indicates amino acids showing differences among species. Orange indicates cyclin box domain in CCNY. ( c ) CCNY expression levels in the several regions of rat brain. Quantification is shown in the lower panel (n = 3; postnatal day 30 male rats). An equal amount of protein (40 μg) from each region was loaded. CTX, cortex; ST, striatum; HC, hippocampus; TH, thalamus; SN, substantia nigra; CB, cerebellum. ( d ) CCNY expression in the DG, CA3, and CA1 in the hippocampus. Postnatal day 30 male rats. ( e , f ) Hippocampal expression levels of CCNY in vivo ( e ) and in vitro ( f ) during development. P, postnatal day; DIV, days in vitro . ( g ) Distribution of CCNY in subcellular fractions of rat brains. H, homogenates; P1, nuclear pellet; P2, crude synaptosomal fraction; S3, cytosolic fraction; LP1, synaptosomal membrane fraction; LP2, synaptic vesicle-enriched fraction; SPM, synaptic plasma membrane fraction; T-sol, Tx-100-soluble fraction; PSD, postsynaptic density fraction. A total of 5 μg of each fraction was loaded in immunoblot experiments. GluA1, PSD-95 and synaptophysin were used as controls. ( h ) CCNY is localized adjacent to PSD-95 in spines. Scale bars, 1 μm. 3D iso-surfaced and volume rendered images with various angle views are shown in hi − hv .

Journal: Scientific Reports

Article Title: Cyclin Y inhibits plasticity-induced AMPA receptor exocytosis and LTP

doi: 10.1038/srep12624

Figure Lengend Snippet: ( a ) Schematic diagram of CCNY domain structure. Numbers indicate amino acid residues. Domain is predicted by ScanProsite ( http://www.expasy.ch/tools/scanprosite/ ) . ( b ) Alignment of CCNY amino acid sequences among human, rat, and mouse was performed using NCBI BLAST program. Blue color indicates amino acids showing differences among species. Orange indicates cyclin box domain in CCNY. ( c ) CCNY expression levels in the several regions of rat brain. Quantification is shown in the lower panel (n = 3; postnatal day 30 male rats). An equal amount of protein (40 μg) from each region was loaded. CTX, cortex; ST, striatum; HC, hippocampus; TH, thalamus; SN, substantia nigra; CB, cerebellum. ( d ) CCNY expression in the DG, CA3, and CA1 in the hippocampus. Postnatal day 30 male rats. ( e , f ) Hippocampal expression levels of CCNY in vivo ( e ) and in vitro ( f ) during development. P, postnatal day; DIV, days in vitro . ( g ) Distribution of CCNY in subcellular fractions of rat brains. H, homogenates; P1, nuclear pellet; P2, crude synaptosomal fraction; S3, cytosolic fraction; LP1, synaptosomal membrane fraction; LP2, synaptic vesicle-enriched fraction; SPM, synaptic plasma membrane fraction; T-sol, Tx-100-soluble fraction; PSD, postsynaptic density fraction. A total of 5 μg of each fraction was loaded in immunoblot experiments. GluA1, PSD-95 and synaptophysin were used as controls. ( h ) CCNY is localized adjacent to PSD-95 in spines. Scale bars, 1 μm. 3D iso-surfaced and volume rendered images with various angle views are shown in hi − hv .

Article Snippet: Primary antibodies against CCNY (Proteintech group), GFP (Roche), GluA1 (a gift from Michael Ehlers, Pfizer Neuroscience), phospho-GluA1 (S845) (Thermo scientific), PSD-95 (Thermo scientific, 7E3-1B8), Synaptophysin (Synaptic Systems), Prox1 (Proteintech group), Ctip2 (Genetex), Py (a gift from D.T.S.

Techniques: Expressing, In Vivo, In Vitro, Membrane, Clinical Proteomics, Western Blot

( a ) Knockdown of CCNY increases basal EPSC AMPA amplitudes with no change in EPSC NMDA amplitudes. Pairwise analysis on the effect of the CCNY shRNA on basal EPSC AMPA amplitude (•, recorded at a holding potential of −70 mV, n = 16) and EPSC NMDA amplitude (●, recorded at a holding potential of +40 mV, n = 16) in the same slice using the same stimulus position and intensity. Red symbols and error bars indicate mean ± SEM. ( b ) The CCNY shRNA-mediated enhancement of basal EPSC AMPA amplitudes was rescued back to the level of untransfected neurons by co-transfecting with shRNA-resistant CCNY-WT construct (●, n = 16) with no effect on EPSC NMDA amplitude (•, n = 16). Red symbols and error bars indicate mean ± SEM. ( c ) Confocal immunostaining of endogenous surface GluA1 in CCNY shRNA transfected or CCNY shRNA-resistant CCNY-WT (Rescue) co-transfected neurons. Scale bar, 5 μm. ( d , e ) Cumulative distribution of surface GluA1 ( d ) and GluN1 ( e ) in dendritic protrusions. Insets display means ± SEM of surface GluA1 ( d ) and GluN1 ( e ) intensity. n = 847, 829, 515 protrusions from n = 24, 27, 17 neurons, respectively in ( d ). n = 227, 361, 287 protrusions from n = 7, 11, 11 neurons, respectively in ( e ). ** p < 0.005 relative to control. ## p < 0.005 relative to shCCNY. ( f – h ) Knockdown of CCNY does not change the total expression level of endogenous GluA1. ( f , g ) Confocal images of endogenous total GluA1 in CCNY shRNA or scrambled shRNA transfected neurons. Neurons were transfected at DIV13−14 and immunostained at DIV16−18. NS, not significant, Scale bar, 20 μm. ( h ) Cultured neurons infected with lentivirus overexpressing CCNY shRNA were applied to immunoblot analysis.

Journal: Scientific Reports

Article Title: Cyclin Y inhibits plasticity-induced AMPA receptor exocytosis and LTP

doi: 10.1038/srep12624

Figure Lengend Snippet: ( a ) Knockdown of CCNY increases basal EPSC AMPA amplitudes with no change in EPSC NMDA amplitudes. Pairwise analysis on the effect of the CCNY shRNA on basal EPSC AMPA amplitude (•, recorded at a holding potential of −70 mV, n = 16) and EPSC NMDA amplitude (●, recorded at a holding potential of +40 mV, n = 16) in the same slice using the same stimulus position and intensity. Red symbols and error bars indicate mean ± SEM. ( b ) The CCNY shRNA-mediated enhancement of basal EPSC AMPA amplitudes was rescued back to the level of untransfected neurons by co-transfecting with shRNA-resistant CCNY-WT construct (●, n = 16) with no effect on EPSC NMDA amplitude (•, n = 16). Red symbols and error bars indicate mean ± SEM. ( c ) Confocal immunostaining of endogenous surface GluA1 in CCNY shRNA transfected or CCNY shRNA-resistant CCNY-WT (Rescue) co-transfected neurons. Scale bar, 5 μm. ( d , e ) Cumulative distribution of surface GluA1 ( d ) and GluN1 ( e ) in dendritic protrusions. Insets display means ± SEM of surface GluA1 ( d ) and GluN1 ( e ) intensity. n = 847, 829, 515 protrusions from n = 24, 27, 17 neurons, respectively in ( d ). n = 227, 361, 287 protrusions from n = 7, 11, 11 neurons, respectively in ( e ). ** p < 0.005 relative to control. ## p < 0.005 relative to shCCNY. ( f – h ) Knockdown of CCNY does not change the total expression level of endogenous GluA1. ( f , g ) Confocal images of endogenous total GluA1 in CCNY shRNA or scrambled shRNA transfected neurons. Neurons were transfected at DIV13−14 and immunostained at DIV16−18. NS, not significant, Scale bar, 20 μm. ( h ) Cultured neurons infected with lentivirus overexpressing CCNY shRNA were applied to immunoblot analysis.

Article Snippet: Primary antibodies against CCNY (Proteintech group), GFP (Roche), GluA1 (a gift from Michael Ehlers, Pfizer Neuroscience), phospho-GluA1 (S845) (Thermo scientific), PSD-95 (Thermo scientific, 7E3-1B8), Synaptophysin (Synaptic Systems), Prox1 (Proteintech group), Ctip2 (Genetex), Py (a gift from D.T.S.

Techniques: Knockdown, shRNA, Construct, Immunostaining, Transfection, Control, Expressing, Cell Culture, Infection, Western Blot

( a , b ) Overexpression of CCNY reduces basal EPSC AMPA amplitudes with no change in EPSC NMDA amplitudes. Pairwise analysis of the effect of CCNY-WT (21 pairs of transfected and untransfected neighboring cells) on basal EPSC AMPA amplitude ( a ) and EPSC NMDA amplitude ( b ). Pairs of transfected and untranfected neighboring cells in the same slice using the same stimulus position and intensity are individually plotted. Red symbol and error bars indicate mean ± SEM. ( c ) Overexpression of CCNY-WT decreases surface level of endogenous GluA1. Confocal immunostaining of endogenous surface GluA1 in CCNY-WT transfected neurons. Neurons were transfected at DIV14−15 and immunostained at DIV15−17. Scale bar, 5 μm. ( d , e ) Cumulative distribution of surface GluA1 ( d ) and GluN1 ( e ) in dendritic protrusions. Insets display means ± SEM of surface GluA1 ( d ) and GluN1 ( e ) intensity. n = 1827, 1699 protrusions from n = 31, 27 neurons, respectively in ( d ). n = 652, 509 protrusions from n = 10, 10 neurons, respectively in ( e ). ** p < 0.0001 relative to control. ( f – h ) Overexpression of CCNY does not change the total level of endogenous GluA1. ( f , g ) Confocal images of endogenous total GluA1 in CCNY-WT transfected neurons. Neurons were transfected at DIV14−15 and immunostained at DIV15−17. NS, not significant, Scale bar, 20 μm. ( h ) Cultured neurons infected with lentivirus overexpressing CCNY-WT were applied to immunoblot analysis.

Journal: Scientific Reports

Article Title: Cyclin Y inhibits plasticity-induced AMPA receptor exocytosis and LTP

doi: 10.1038/srep12624

Figure Lengend Snippet: ( a , b ) Overexpression of CCNY reduces basal EPSC AMPA amplitudes with no change in EPSC NMDA amplitudes. Pairwise analysis of the effect of CCNY-WT (21 pairs of transfected and untransfected neighboring cells) on basal EPSC AMPA amplitude ( a ) and EPSC NMDA amplitude ( b ). Pairs of transfected and untranfected neighboring cells in the same slice using the same stimulus position and intensity are individually plotted. Red symbol and error bars indicate mean ± SEM. ( c ) Overexpression of CCNY-WT decreases surface level of endogenous GluA1. Confocal immunostaining of endogenous surface GluA1 in CCNY-WT transfected neurons. Neurons were transfected at DIV14−15 and immunostained at DIV15−17. Scale bar, 5 μm. ( d , e ) Cumulative distribution of surface GluA1 ( d ) and GluN1 ( e ) in dendritic protrusions. Insets display means ± SEM of surface GluA1 ( d ) and GluN1 ( e ) intensity. n = 1827, 1699 protrusions from n = 31, 27 neurons, respectively in ( d ). n = 652, 509 protrusions from n = 10, 10 neurons, respectively in ( e ). ** p < 0.0001 relative to control. ( f – h ) Overexpression of CCNY does not change the total level of endogenous GluA1. ( f , g ) Confocal images of endogenous total GluA1 in CCNY-WT transfected neurons. Neurons were transfected at DIV14−15 and immunostained at DIV15−17. NS, not significant, Scale bar, 20 μm. ( h ) Cultured neurons infected with lentivirus overexpressing CCNY-WT were applied to immunoblot analysis.

Article Snippet: Primary antibodies against CCNY (Proteintech group), GFP (Roche), GluA1 (a gift from Michael Ehlers, Pfizer Neuroscience), phospho-GluA1 (S845) (Thermo scientific), PSD-95 (Thermo scientific, 7E3-1B8), Synaptophysin (Synaptic Systems), Prox1 (Proteintech group), Ctip2 (Genetex), Py (a gift from D.T.S.

Techniques: Over Expression, Transfection, Immunostaining, Control, Cell Culture, Infection, Western Blot

( a , b ) SEP-GluA1 was imaged before and after glycine stimulation. Arrows indicate spines showing the changes of SEP-GluA1 intensity during glycine-induced LTP. Pseudocolor intensity scale bar is shown. Scale bars, 1 μm each. See also for more images. ( c ) Data represent means ± SEM of ΔF/ F 0 from spines. n = 32, 41, 31, 31 spines from n = 7, 5, 6, 6 neurons for control, CCNY-WT, shCCNY, and shCCNY + rescue, respectively. Bonferroni’s post-hoc . ( d ) The number of SEP-GluA1 inserted and accumulated per 100 μm of dendrite. n = 11, 10, 10, 6 neurons from left to right. * p < 0.01 relative to control, ** p < 0.001 relative to control, ## p < 0.005 relative to shCCNY, student’s t test. ( e ) Total expression level of CCNY is unchanged during glycine-induced LTP. Cultured hippocampal neurons infected with lentivirus overexpressing CCNY-WT or CCNY shRNA were applied to immunoblot analysis before and 20 minutes after glycine stimulation. ( f ) Data represent means ± SEM of CCNY level. n = 12, 5, 7 for control, CCNY-WT, and shCCNY, respectively. NS, not significant. ( g ) CCNY regulates phosphorylation of GluA1 at Ser845 during glycine-induced LTP. Cultured hippocampal neurons infected with lentivirus overexpressing CCNY shRNA or scrambled shRNA were immunoblotted with anti-phospho-GluA1 (S845) antibodies before and 15–20 min after glycine stimulation. ( h ) Data represent means ± SEM of phosphorylated levels of GluA1 at S845. n = 7. * p < 0.05, ** p < 0.005, student’s t test.

Journal: Scientific Reports

Article Title: Cyclin Y inhibits plasticity-induced AMPA receptor exocytosis and LTP

doi: 10.1038/srep12624

Figure Lengend Snippet: ( a , b ) SEP-GluA1 was imaged before and after glycine stimulation. Arrows indicate spines showing the changes of SEP-GluA1 intensity during glycine-induced LTP. Pseudocolor intensity scale bar is shown. Scale bars, 1 μm each. See also for more images. ( c ) Data represent means ± SEM of ΔF/ F 0 from spines. n = 32, 41, 31, 31 spines from n = 7, 5, 6, 6 neurons for control, CCNY-WT, shCCNY, and shCCNY + rescue, respectively. Bonferroni’s post-hoc . ( d ) The number of SEP-GluA1 inserted and accumulated per 100 μm of dendrite. n = 11, 10, 10, 6 neurons from left to right. * p < 0.01 relative to control, ** p < 0.001 relative to control, ## p < 0.005 relative to shCCNY, student’s t test. ( e ) Total expression level of CCNY is unchanged during glycine-induced LTP. Cultured hippocampal neurons infected with lentivirus overexpressing CCNY-WT or CCNY shRNA were applied to immunoblot analysis before and 20 minutes after glycine stimulation. ( f ) Data represent means ± SEM of CCNY level. n = 12, 5, 7 for control, CCNY-WT, and shCCNY, respectively. NS, not significant. ( g ) CCNY regulates phosphorylation of GluA1 at Ser845 during glycine-induced LTP. Cultured hippocampal neurons infected with lentivirus overexpressing CCNY shRNA or scrambled shRNA were immunoblotted with anti-phospho-GluA1 (S845) antibodies before and 15–20 min after glycine stimulation. ( h ) Data represent means ± SEM of phosphorylated levels of GluA1 at S845. n = 7. * p < 0.05, ** p < 0.005, student’s t test.

Article Snippet: Primary antibodies against CCNY (Proteintech group), GFP (Roche), GluA1 (a gift from Michael Ehlers, Pfizer Neuroscience), phospho-GluA1 (S845) (Thermo scientific), PSD-95 (Thermo scientific, 7E3-1B8), Synaptophysin (Synaptic Systems), Prox1 (Proteintech group), Ctip2 (Genetex), Py (a gift from D.T.S.

Techniques: Control, Expressing, Cell Culture, Infection, shRNA, Western Blot, Phospho-proteomics

LTP stimulus induces AMPA receptor insertion to the surface (middle panel). Overexpression of CCNY (CCNY OE) inhibits plasticity-induced AMPA receptor exocytosis in the spine, therefore blocking LTP (left panel). Knockdown of CCNY (CCNY KD) significantly increases plasticity-induced phosphorylation of AMPA receptors (p845-GluA1) and their delivery to the plasma membrane in the spine, therefore enhancing LTP (right panel).

Journal: Scientific Reports

Article Title: Cyclin Y inhibits plasticity-induced AMPA receptor exocytosis and LTP

doi: 10.1038/srep12624

Figure Lengend Snippet: LTP stimulus induces AMPA receptor insertion to the surface (middle panel). Overexpression of CCNY (CCNY OE) inhibits plasticity-induced AMPA receptor exocytosis in the spine, therefore blocking LTP (left panel). Knockdown of CCNY (CCNY KD) significantly increases plasticity-induced phosphorylation of AMPA receptors (p845-GluA1) and their delivery to the plasma membrane in the spine, therefore enhancing LTP (right panel).

Article Snippet: Primary antibodies against CCNY (Proteintech group), GFP (Roche), GluA1 (a gift from Michael Ehlers, Pfizer Neuroscience), phospho-GluA1 (S845) (Thermo scientific), PSD-95 (Thermo scientific, 7E3-1B8), Synaptophysin (Synaptic Systems), Prox1 (Proteintech group), Ctip2 (Genetex), Py (a gift from D.T.S.

Techniques: Over Expression, Blocking Assay, Knockdown, Phospho-proteomics, Clinical Proteomics, Membrane